Annovis Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Annovis Bio, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue0.000.000.000.000.00
Cost of Revenue0.000.000.000.000.00
Gross Profit0.000.000.000.000.00
Operating Expenses
Research & Development20.0038.7916.528.483.05
Selling, General & Administrative6.706.249.006.063.59
Operating Expenses26.6945.0425.5114.506.64
Operating Income-26.69-45.04-25.51-14.50-6.64
Other Income/Expense
Interest Income0.330.670.180.010.05
Interest Expense1.850.000.000.000.00
Other Income/Expense3.63-11.840.000.041.13
Income
Income Before Tax-24.59-56.20-25.33-14.49-5.46
Income Tax Expense0.000.000.000.000.00
Net Income-24.59-56.20-25.33-14.49-5.46
Net Income - Continuous Operations-24.59-56.20-25.33-14.490.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-26.69-45.04-25.51-14.500.00
EBIT-26.69-45.04-25.51-14.50-6.64
Depreciation & Amortization0.000.000.000.000.00
Earnings Per Share
Basic EPS-2.00-6.00-3.00-2.00-1.00
Diluted EPS-2.00-6.00-3.00-2.00-1.00
Basic Shares Outstanding12.189.028.167.636.31
Diluted Shares Outstanding12.249.028.167.636.31